-
FDA warns of serious side effects from certain antibiotics
SILVER SPRING, Md. — The Food and Drug Administration issued a safety message late last week concerning the potential for serious side effects associated with fluoroquinolone antibiotics.Pfizer to acquire Anacor Pharmaceuticals
NEW YORK — Pfizer announced Monday that it would be acquiring Anacor Pharmaceuticals for about $5.2 billion, a transaction that has been approved by both companies’ boards of directors. Currently, Anacor’s flagship asset, crisaborole — a non-steroidal topical PDE inhibitor with anti-inflammatory properties — is currently awaiting review from the Food and Drug Administration to treat mild to moderate eczema.